IL2RG and B-cell chronic lymphocytic leukemia: To explore the relevance of these findings in human CLL models, we then xenotransplanted the human MEC-1 CLL cell line into immunocompromised NOD/SCID/IL2rγ−/− (NSG) mice and treated these animals with anti-RANKL antibodies.